Aaron Schain
Beth Israel Deaconess Medical Center(US)Harvard University(US)
Publications by Year
Research Areas
Migraine and Headache Studies, Trigeminal Neuralgia and Treatments, Neuroinflammation and Neurodegeneration Mechanisms, Botulinum Toxin and Related Neurological Disorders, Neuroscience of respiration and sleep
Most-Cited Works
- → Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques(2015)723 cited
- → CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis(2010)267 cited
- → Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache(2017)259 cited
- → Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy(2014)196 cited
- → Fremanezumab—A Humanized Monoclonal Anti-CGRP Antibody—Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors(2017)187 cited
- → Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody(2017)159 cited
- → Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial(2015)155 cited
- → Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition(2011)109 cited
- → Activation of pial and dural macrophages and dendritic cells by cortical spreading depression(2018)103 cited
- → Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier(2019)94 cited